Malaria is one of the most devastating infectious diseases of humans. It is problematic
clinically and economically as it prevails in poorer countries and regions, strongly hindering …

This article is inter alia a brief, first-stop guide to possible adverse events (AEs) associated
with tafenoquine (TQ) intake. Safety and efficacy findings for TQ in Plasmodium vivax …

Metabolically quiescent pathogens can persist in a viable non-replicating state for months or
even years. For certain infectious diseases, such as tuberculosis, cryptococcosis …

Plasmodium vivax relapse is one of the major causes of sustained global malaria
transmission. Primaquine (PQ) is the only commercial drug available to prevent relapses …

Enhanced therapeutic efficacy achieved in treating Plasmodium vivax malaria with an 8-
aminoquinoline (8-AQ) drug such as primaquine (PQ) together with a partner drug such as …

Malaria is widespread throughout the world and affects many animal species. Although the
origin of this vector-borne disease was discovered more than a century ago, several aspects …

Background In the Peruvian Amazon, Plasmodium vivax malaria transmission is maintained
due to the high frequency of recurrences. By understanding the recurrence rates of …

Chloroquine (CQ) is the first-line treatment for Plasmodium vivax malaria in most countries
where malaria is endemic. Monitoring P. vivax CQ resistance (CQR) is critical but remains …

Plasmodium vivax is the most widely distributed human malaria parasite representing 36.3%
of disease burden in the South-East Asia region and the most predominant species in the …

Background We aimed to analyze the epidemiology, clinical characteristics, and outcomes
of malaria caused by Plasmodium vivax among military members of the Republic of Korea …